Celldex Therapeutics
CLDX
#4211
Rank
C$4.26 B
Marketcap
C$54.35
Share price
-3.31%
Change (1 day)
79.32%
Change (1 year)

Celldex Therapeutics (CLDX) Fails to deliver data

Key failure to deliver metrics for Celldex Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019

Volume in USD (price x number of shares), data since 2019

Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026C$3.16 M-72.74%
2025C$11.6 M105.38%
2024C$5.65 M43.21%
2023C$3.94 M-85.8%
2022C$27.79 M-36.31%
2021C$43.63 M146.97%
2020C$17.66 M1075.04%
2019C$1.5 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
C$0.20 BC$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$25.65 MC$0.43 B๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$37.06 MC$0.18 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AC$0.12 M๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
N/AC$3.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$3.41 MC$5.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$4.21 MC$7.02 M๐Ÿ‡บ๐Ÿ‡ธ USA